3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Thymus Neoplasms
1
Small Cell Lung Carcinoma
1
Resected Pancreatic Adenocarcinoma
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Meningioma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma
1
Carcinoid Tumor
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
7
Magnetic Resonance Spectroscopy
5
Cisplatin
5
Specimen Handling
4
Radiation
4
Radiotherapy
3
Biopsy
3
motexafin gadolinium
2
fludarabine
2
Vorinostat
2
Radiosurgery
2
Fluorouracil
2
Cyclophosphamide
2
zimberelimab
1
peposertib
1
ipatasertib
1
fludarabine phosphate
1
dl1520
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Lidocaine
1
L 778,123
1
Immunohistochemistry
1
Hyperthermia, Induced
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Oropharyngeal Neoplasms
×
Proton Therapy
×
Clear all
NCT06446713
2025-04-03
PIRATES
University Medical Center Groningen
Phase 1
Recruiting
17 enrolled